(3-Chloro-4-(cyclopentylcarbamoyl)phenyl)boronic acid, 95.0%, 250mg

2,4,6-Trifluorobenzenesulfonamide, 25g

2-n-Butoxybenzoic acid, 95.0%, 250mg

(S)-2-Amino-2-(3-fluorophenyl)ethanol, 95.0%, 5g

5-Hydroxypyrazine-2-carboxylic acid, 97.0%, 100g

N-(Chloroacetyl)-3-fluoroaniline, 97.0%, 5g

Dish ROTILABO® with grooved base, 430 mm, white, 1 Piece

3-(3-Methylisoxazol-5-yl)propan-1-ol, 95.0%, 5g

GC capillary column ROTI®Cap-1 MS, 25 m, 0.20 mm, 0.20 µm, 1 Piece(s)

N-(1-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-(2-methoxyethoxy)tetrahydrofuran-2-yl)-5-methyl-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide, 95+%, 5g

5-Cyano-2-(trifluoromethyl)benzoic acid, 98%, 1g

5-Bromo-2-fluorobenzimidamide, 97.0%, 100mg

3-(4-Fluorophenyl)-2,2-dimethylpropanoic acid, 95.0%, 1g